BREAKING: EyeQue shrinks the eye doctor's autorefractor onto a phone screen $57M raised since 2015 Five CES Innovation Awards and counting Vision test in under 3 minutes Optics licensed from MIT Newark, California BREAKING: EyeQue shrinks the eye doctor's autorefractor onto a phone screen $57M raised since 2015 Five CES Innovation Awards and counting Vision test in under 3 minutes Optics licensed from MIT Newark, California
Company Profile / Digital Health

EyeQue Corporation

The eye exam that fits in your pocket. Clip a small lens onto your phone, merge a red line into a green one, and read your own eyes.

Founded · 2015 · Newark, California
Founders · John Serri & Tibor Laczay
Funding · $57M+ · Series C
EyeQue smartphone vision-testing devices and bundle
EyeQue's kit, photographed like a still life. Somewhere in that little stack of plastic is a machine that used to take up half a room.
Share LinkedIn Twitter / X Facebook Instagram
Who They Are Now

A vision lab that lives in a junk drawer

Somewhere right now, a person who is nowhere near an eye doctor is holding a phone to their face. On the screen, a green line and a red line drift apart. Thumb on a side button, they nudge the two until they snap into a single yellow stripe. Eight times for one eye, eight for the other, and in under three minutes a number appears - a measurement of exactly how their eyes bend light. That device costs less than a tank of gas. That is EyeQue.

EyeQue Corporation builds smartphone-attached optical devices and apps that let ordinary people measure their own vision at home. Headquartered in Newark, California, the company has turned the autorefractor - the intimidating chin-rest machine in every optometry office - into a clip-on gadget and a free app. The result is what it calls your EyeGlass Numbers: the figures you need to order glasses online without ever sitting in a waiting room.

“A clinically-tested eye test you run yourself, in your kitchen, before your coffee gets cold.”The pitch, more or less
The Problem They Saw

Eyesight is universal. Eye care is not.

Most of the planet needs vision correction at some point. Far fewer people live within easy reach of someone qualified to measure it. For decades the only way to learn your prescription was to physically travel to a clinic, sit behind a machine the size of a microwave, and pay for the privilege. For a billion-plus people, that machine may as well be on the moon.

The irony is hard to miss. We carry supercomputers in our pockets, track our steps, our sleep and our heart rate by the second - and yet the single number that decides whether the world looks sharp or blurry still required an appointment. EyeQue's founders looked at that gap and saw not a medical problem but a logistics one. The optics were solvable. The access was the hard part.

“We track everything else about our bodies on a phone. Why not the eyes?”The question EyeQue was built to answer
The Founders' Bet

“How hard could a little piece of plastic be?”

In 2015, at a biotech networking party thrown by their wives, two friends got to talking. One was John Serri, a physicist with an MIT PhD in atomic physics and a career spanning Bell Labs, Lockheed Martin and Trimble Navigation. The other was Tibor Laczay, CEO of the online eyewear company Zenni Optical. Serri had been thinking about retirement. Then someone said the famous last words of every great hardware company: how hard could it be to build a little piece of plastic?

Hard, as it turned out - but not impossible. The pair licensed optical refraction technology patented at MIT, opened a small office in the Bay Area, and built the Personal Vision Tracker. Their first bet was contrarian: skip the venture capital and self-fund. Their second was bolder still - take it to Kickstarter and let the crowd decide whether at-home vision testing deserved to exist. The crowd said yes.

2015
Year founded
MIT
Patent source
~17
Team size
5
CES awards
The Product

The autorefractor, on a diet

The flagship is VisionCheck - and later VisionCheck 2 - a small refractometer that straps over your phone's screen. Pressed to your eye, it shows two colored lines you align by feel. Repeat the dance across the lens, and the app calculates how light refracts into your eye, covering nearsightedness, farsightedness and astigmatism. What used to demand a trained technician now takes a curious adult and a few quiet minutes.

Around that core, EyeQue built a small constellation of tools - because a prescription is only half of buying glasses online.

VisionCheck 2

The clip-on autorefractor that turns your phone into a vision test for refractive error.

PDCheck

Measures pupillary distance - the number you need so online lenses sit in front of your actual pupils.

MyReaderNumber

Finds the right strength for over-the-counter reading glasses, no guessing at the pharmacy.

Try-On Glasses

Low-cost lenses to sanity-check your at-home results before buying the real pair.

EyeQue is careful with its language. It never says “prescription,” because the test is self-administered. It says EyeGlass Numbers. That single word swap is the difference between a regulated medical claim and a consumer measurement - and it tells you everything about how seriously the company takes the line between empowerment and overpromising.

“Merge the red line into the green until you see yellow. Do it eight times. Congratulations, you have measured your own eye.”How VisionCheck actually works

The EyeQue Timeline

FROM A PARTY JOKE TO A SERIES C
2015
Founded in the Bay AreaSerri and Laczay license MIT optics and start building the Personal Vision Tracker.
2016
Kickstarter launchThe crowd funds the original at-home vision tracker - self-funding meets crowd validation.
2018
$11.2M Series BTotal raised hits $16.2M to scale at-home vision testing to the masses.
2019
VisionCheck wins CESNamed the world's first automated at-home eye test; CES 2019 Innovation honoree.
2020
Try-On Glasses & more awardsLow-cost verification lenses launch; the Vision Monitoring Kit takes another CES award.
2021
VisionCheck 2, EyecareLive, Series CFourth and fifth CES awards, a telehealth partnership, and ~$40M Series C pushing the total past $57M.
The Proof

Awards are nice. Money is louder.

Skepticism is the correct response to any gadget that promises to replace a professional. EyeQue knows this, which is why the receipts matter. Five CES Innovation Awards across 2019-2021 say the industry took the engineering seriously. More than $57 million raised - capped by a roughly $40 million Series C in 2021 - says investors did too.

Reviews, to be fair, are mixed in the honest way real products are. Many users report sharper glasses than before; at least one optometrist told a reviewer the device struggled with severe astigmatism. EyeQue's own framing is the responsible one: it complements eye doctors, it doesn't retire them. A comprehensive exam still catches glaucoma and cataracts that no phone lens can see.

Money raised, round by round

CUMULATIVE CAPITAL, APPROX. (USD)
Series B '18
$16.2M total
Series C '21
+$40.35M
Total raised
$57M+

Figures approximate, drawn from public funding announcements (Business Wire, Vision Monday).

“Five CES awards. Fifty-seven million dollars. One very small piece of plastic.”The short version of the proof

And it isn't going it alone. EyeQue partnered with EyecareLive in 2021 to put a licensed eye doctor on the other end of the app, and its measurements flow naturally into online eyewear - a path Laczay knows well from Zenni Optical. The customers are exactly who you'd expect once you stop assuming everyone lives near a clinic: parents keeping tabs on a child's changing eyes, online glasses shoppers who need a pupillary-distance number, travelers, students, and people in places where the nearest optometrist is a serious commute. EyeQue has reported device sales in the tens of thousands and an app footprint that spans well beyond the United States.

Independent reviewers tend to land in the same place. The gadget press calls it clever and genuinely useful; clinicians call it a helpful first read, not a substitute for a dilated exam. Both can be true. A tool that gets a reasonable number into the hands of someone who otherwise had none is, on balance, a win - even if it occasionally sends a tricky case back to a professional, which is rather the point.

The Mission

Make eye care accessible to all

Strip away the awards and the funding and you're left with a fairly stubborn idea: that your eyesight is your data, and you should be able to check it without an appointment, an insurance card, or a long drive. EyeQue treats vision the way fitness apps treat steps - something you measure, log, and watch change over time, on your own terms.

That's a quietly radical position in healthcare, where the default is to centralize. EyeQue decentralizes. It hands the instrument to the patient and trusts them to use it. The company isn't trying to abolish the optometrist; it's trying to reach the enormous number of people who never see one at all.

Things that amuse and inform

  • Co-founder John Serri earned his MIT physics PhD in 1980 - long before phones had cameras to point at your eye.
  • The whole company traces back to a joke at a networking party about a “little piece of plastic.”
  • EyeQue avoids the word “prescription” on purpose - the self-run result is an “EyeGlass Number.”
  • The test ends when red and green become a single yellow line - a tiny moment of optical satisfaction.
  • The device is a shrunken cousin of the giant autorefractor you stare into at the eye doctor.
Why It Matters Tomorrow

The waiting room is optional now

As EyeQue layers AI into its measurements and expands telehealth links to real doctors, the trajectory points somewhere bigger than glasses. Vision becomes a tracked vital sign. A blurry change over months becomes a data point you can act on - and, increasingly, share with a clinician on the same app.

Back to that person holding a phone to their face, nowhere near an eye doctor. A decade ago they'd have squinted through another blurry year, or driven hours for an exam, or simply gone without. Now the green line slides into the red, the yellow appears, and a number lands in their pocket. The clinic didn't come closer. EyeQue just made the distance stop mattering.

“The eye doctor didn't move. EyeQue made the distance irrelevant.”EyeQue Corporation, the closing argument